Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis (Q36653022)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 28 December 2012

Language	Label	Description	Also known as
English	Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis	scientific article published on 28 December 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Matthew R Cooperberg

object named as

Matthew R Cooperberg

1

0 references

Ashutosh Tewari

7

object named as

Ashutosh K Tewari

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Naren R Ramakrishna

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Steven B Duff

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kathleen E Hughes

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sara Sadownik

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Joseph A Smith

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

28 December 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

BJU International

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

111

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

437-450

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Cost implications of the rapid adoption of newer technologies for treating prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Impact of age at diagnosis on prostate cancer treatment and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Outcomes of active surveillance for men with intermediate-risk prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Time trends and local variation in primary treatment of localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Active surveillance for early-stage prostate cancer: review of the current literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Guideline for the management of clinically localized prostate cancer: 2007 update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

30 September 2017

Comparative effectiveness of minimally invasive vs open radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

28 June 2018

Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Cumulative cost pattern comparison of prostate cancer treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

20 September 2018

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

21 October 2018

Is Proton Beam Therapy Cost Effective in the Treatment of Adenocarcinoma of the Prostate?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

21 October 2018

Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587031

21 October 2018

Radical prostatectomy versus observation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11597.X

21 January 2018

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

United States life tables, 2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era

1 reference

https://pubmed.ncbi.nlm.nih.gov/23279038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-410X.2012.11597.X

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36653022&oldid=2072377051"